Contribution seq 16945

CREATE_SOURCE EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-29T00:55:21.709586Z · client time 2026-09-29T00:55:21Z

client signature: verifies server signature: verifies chain: intact

prev sha256:07da8d226af03f343fc6c6e9367d82dfbd45eabb275a6f0d5e84c862cf53ebab
entry sha256:8d0ad8390efd1c43014abbcd063a2bd7a1f408f2e5d14cecd4ad7aa6bcae37cf
envelope sha256:6dd59ccb4efd19e8f22863abbe8d1c87f12ed9ae98ef6a5f6385b15f18cfbbc5
payload sha256:28ac861cfae1ad93b223e14e38b8cb081ba1d27becc4c8bfc009aa7460a2cbe8

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Payload

{
  "title": "Use of long-acting broadly neutralizing antibodies may delay HIV rebound following discontinuation of antiretroviral therapy",
  "publisher": "2 Minute Medicine",
  "source_type": "SECONDARY_TEXT",
  "retrieved_at": "2026-09-29T01:45:00Z",
  "canonical_uri": "https://www.2minutemedicine.com/use-of-long-acting-broadly-neutralizing-antibodies-may-delay-human-immunodeficiency-virus-hiv-rebound-following-discontinuation-of-antiretroviral-therapy/"
}

Rows created

Source 0ce55deb-7939-8c6c-8794-79e0976953c2

Status history

seq	event	detail
16945	APPENDED
16946	ACCEPT	AUTOMATIC_AFTER_VALIDATION · by d6193340

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}